Financial insights of CAI

MyFinsight

For the year ending 2025-12-31, CAI made $812,033K in revenue. -$537,957K in net income. Net profit margin of -66.25%.

Income Statement	2025-12-31
Total revenue	812,033
Cost of services-Molecular Profiling Services	262,353
Selling and marketing expense	167,506
General and administrative expense (see note 11)	224,965
Research and development expense	101,584
Total costs and operating expenses	766,920
Income (loss) from operations	45,113
Interest income	16,497
Interest expense	56,853
Changes in fair value of financial instruments	-52,285
Other expense, net	-20,560
Total other expense, net	-113,201
Loss before income taxes and provision for income taxes	-68,088
Provision for income taxes	0
Net loss	-68,088
Deemed dividend from series d redeemable convertible preferred stock (see note 6)	384,436
Adjustments of redeemable convertible preferred stock to redemption value	85,433
Net loss attributable to common shareholders basic	-537,957
Net loss attributable to common shareholders diluted	-537,957

Basic EPS	-3.22
Diluted EPS	-3.22
Basic Average Shares	167,205,616
Diluted Average Shares	167,205,616